ZNF470 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 9.48670031419852E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.43379974559821E-10 |
Normal-vs-Stage2 |
4.37910000000707E-05 |
Normal-vs-Stage3 |
1.45620000502333E-08 |
Normal-vs-Stage4 |
4.33990000003881E-06 |
Stage1-vs-Stage2 |
3.159600E-01 |
Stage1-vs-Stage3 |
3.598000E-01 |
Stage1-vs-Stage4 |
6.084000E-01 |
Stage2-vs-Stage3 |
8.495600E-01 |
Stage2-vs-Stage4 |
8.402000E-01 |
Stage3-vs-Stage4 |
9.350000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
4.90979479295106E-11 |
Normal-vs-AfricanAmerican |
9.88939996560134E-09 |
Normal-vs-Asian |
2.322100E-03 |
Caucasian-vs-AfricanAmerican |
7.360000E-01 |
Caucasian-vs-Asian |
7.170800E-01 |
AfricanAmerican-vs-Asian |
8.092200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.35513863755932E-12 |
Normal-vs-Female |
1.71418999999062E-05 |
Male-vs-Female |
1.199500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
2.9741999996169E-07 |
Normal-vs-Extreme_Weight |
8.03956901052061E-12 |
Normal-vs-Obese |
1.84969999994511E-06 |
Normal-vs-Extreme_Obese |
1.59035999999224E-05 |
Normal_Weight-vs-Extreme_Weight |
1.616180E-01 |
Normal_Weight-vs-Obese |
5.137400E-01 |
Normal_Weight-vs-Extreme_Obese |
6.144800E-01 |
Extreme_Weight-vs-Obese |
2.877800E-02 |
Extreme_Weight-vs-Extreme_Obese |
7.985400E-01 |
Obese-vs-Extreme_Obese |
3.970800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.77320000000125E-05 |
Normal-vs-Age(41-60Yrs) |
3.23729998363831E-09 |
Normal-vs-Age(61-80Yrs) |
4.75739447836077E-11 |
Normal-vs-Age(81-100Yrs) |
1.53520000045759E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.949200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.545600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.112010E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.256400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.680400E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.788100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.22560003759753E-09 |
Normal-VS-Type2 PRCC |
1.61315405478035E-13 |
Normal-VS-KIRP CIMP |
2.142100E-03 |
Normal-VS-Unclassified PRCC |
1.47039999953691E-07 |
Type1 PRCC-VS-Type2 PRCC |
1.648340E-04 |
Type1 PRCC-VS-KIRP CIMP |
7.046600E-01 |
Type1 PRCC-VS-Unclassified PRCC |
3.077400E-01 |
Type2 PRCC-VS-KIRP CIMP |
4.100300E-02 |
Type2 PRCC-VS-Unclassified PRCC |
8.761800E-02 |
KIRP CIMP-VS-Unclassified PRCC |
3.814800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.79216707719388E-14 |
Normal-vs-N1 |
1.11589999995942E-06 |
Normal-vs-N2 |
2.45799999999408E-05 |
N0-vs-N1 |
1.163400E-01 |
N0-vs-N2 |
3.595000E-01 |
N1-vs-N2 |
1.737980E-01 |
|
|